Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 6, Pages 2227
Publisher
MDPI AG
Online
2020-03-24
DOI
10.3390/ijms21062227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
- (2019) Andrea DeCensi et al. JOURNAL OF CLINICAL ONCOLOGY
- Hormonal strategies in gynecologic cancer: Bridging biology and therapy
- (2018) Wilberto Nieves-Neira et al. GYNECOLOGIC ONCOLOGY
- Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial
- (2017) Ian Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women
- (2016) L. A. Brinton et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
- (2016) Aliana Guerrieri-Gonzaga et al. INTERNATIONAL JOURNAL OF CANCER
- Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
- (2016) Michaela A. Onstad et al. JOURNAL OF CLINICAL ONCOLOGY
- Aromatase expression and regulation in breast and endometrial cancer
- (2016) Hong Zhao et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
- (2016) Sarah Kitson et al. MODERN PATHOLOGY
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
- (2015) N. Colombo et al. ANNALS OF ONCOLOGY
- The therapeutic significance of aromatase inhibitors in endometrial carcinoma
- (2014) Chao Gao et al. GYNECOLOGIC ONCOLOGY
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
- (2013) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- (2008) N. E Allen et al. ENDOCRINE-RELATED CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started